QBIO — Q BioMed Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.25m
- $0.28m
Annual cashflow statement for Q BioMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.27 | -10.3 | -13.5 | -8.24 | -2.05 |
| Amortisation | |||||
| Non-Cash Items | 2.87 | 4.43 | 6.9 | 3.09 | 2.19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.052 | 1.7 | 0.313 | 0.797 | 1.75 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.45 | -4.11 | -6.23 | -4.3 | 1.94 |
| Capital Expenditures | -0.5 | 0 | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | -3.14 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.5 | 0 | — | — | -3.14 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.81 | 1.59 | 6.24 | 4.47 | 0.908 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.86 | -2.51 | 0.005 | 0.167 | -0.294 |